Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
2014
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.
2000
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
2010
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
2015
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
2010
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)
2015
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
2016 Standout
Molecular imaging in drug development
2008 Standout
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial
2009
Lobeline Attenuates Methamphetamine-Induced Changes in Vesicular Monoamine Transporter 2 Immunoreactivity and Monoamine Depletions in the Striatum
2004
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Relationship between subjective effects of cocaine and dopamine transporter occupancy
1997 Nature
Getting Formal with Dopamine and Reward
2002 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Synthesis, in vivo biodistribution and dosimetry of [11C]N-Methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist
1995
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
2014
Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized Phase III Trial
2011
Targeting glutamine metabolism in myeloproliferative neoplasms
2015
Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse
1994
Randomized, placebo‐controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting
2008
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
2014
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Development of a therapeutic vaccine for the treatment of cocaine addiction
1997
Neurokinin-1 and novel serotonin antagonists for postoperative and postdischarge nausea and vomiting
2010
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
2014
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Neuronal nicotinic receptors in the human brain
2000
Anatomically distinct dopamine release during anticipation and experience of peak emotion to music
2011 Standout
MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro
2001
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Different Doses of Palonosetron Versus Placebo for Preventing Postoperative Nausea and Vomiting
2008
A Functional Magnetic Resonance Imaging (fMRI) Study of Cue-Induced Smoking Craving in Virtual Environments
2005
Monitoring gene therapy with reporter gene imaging
2001
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Update on the Management of Postoperative Nausea and Vomiting and Postdischarge Nausea and Vomiting in Ambulatory Surgery
2010
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
The Effect of the Repeated Administration of the Compound 3,4-Methylenedioxymethamphetamineon the Response of Rats to the5-HT<sub>2A,C</sub> Receptor Agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
1997
A review of central 5-HT receptors and their function
1999 Standout
The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human Brain
2002
Differences between smokers and nonsmokers in regional gray matter volumes and densities
2003
Brain Reward Circuitry
2002
Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial
2015
Theranostic Lipid Nanoparticles for Cancer Medicine
2015
The Reward Circuit: Linking Primate Anatomy and Human Imaging
2009 Standout
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
2002
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
2001 StandoutNature
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
2015
Drug Dependence, a Chronic Medical Illness
2000 Standout
Drugging the undruggable RAS: Mission Possible?
2014
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Neurocircuitry of Addiction
2009 Standout
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field
2014
Dopamine, learning and motivation
2004 Standout
The integrated stress response
2016 Standout
3d Transition Metals for C–H Activation
2018 Standout
A convenient synthesis of indoloquinolinones via 3-arylation of indole-2-carboxamides and PIDA-mediated C–N bond formation
2015
Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis
2015
Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction
2013
Fundamentals of cancer metabolism
2016 Standout
A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy.
2010
Downregulation ofGLS2in glioblastoma cells is related to DNA hypermethylation but not to the p53 status
2015
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation
2017 StandoutNobel
New photosensitizers for photodynamic therapy
2016 Standout
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
2015
18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography
2016
Simultaneously Targeting Tissue Transglutaminase and Kidney Type Glutaminase Sensitizes Cancer Cells to Acid Toxicity and Offers New Opportunities for Therapeutic Intervention
2014
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin
1998
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
2015
A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression
2017 StandoutNobel
Works of Marigo Stathis being referenced
Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen
2012
The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo
2010
In vivo biodistribution of two [18F]-labelled muscarinic cholinergic receptor ligands: 2-[18F]- and 4-[18F]-fluorodexetimide
1991
Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells
2014
The discovery and structure–activity relationships of indole-based inhibitors of glutamate carboxypeptidase II
2010
Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
2009
Rate of binding of various inhibitors at the dopamine transporter in vivo
1995
[125/123I]IPH: A radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors
1997
Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors
1992
Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects
2012
Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: A ligand for in vitro and in vivo studies of serotonin receptors
1991
Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors
2012
Palonosetron Exhibits Unique Molecular Interactions with the 5-HT3 Receptor
2008
In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors
1990
Additional binding mechanism of palonosetron to the 5-HT3 receptor versus first generation 5-HT3 receptor antagonists
2007
Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors.
1997
High-Affinity No-Carrier-Added99mTc-Labeled Chemotactic Peptides for Studies of Inflammation in Vivo
1998